| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,627 |
2,521 |
$159K |
| 80061 |
Lipid panel |
11,922 |
11,507 |
$123K |
| 80053 |
Comprehensive metabolic panel |
13,937 |
12,741 |
$104K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,386 |
5,165 |
$104K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,332 |
3,171 |
$97K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,335 |
3,176 |
$93K |
| 80050 |
General health panel |
5,808 |
5,654 |
$81K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,832 |
10,395 |
$79K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,502 |
2,381 |
$70K |
| 87481 |
|
1,278 |
1,210 |
$69K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,477 |
6,202 |
$69K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,342 |
1,011 |
$68K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,076 |
8,126 |
$47K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,294 |
1,229 |
$39K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
2,148 |
2,069 |
$35K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,120 |
1,071 |
$32K |
| 84439 |
|
4,418 |
4,230 |
$31K |
| 82607 |
|
2,556 |
2,468 |
$30K |
| 86003 |
|
503 |
457 |
$29K |
| 82728 |
|
2,646 |
2,538 |
$28K |
| 85027 |
|
5,066 |
4,778 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,933 |
3,621 |
$24K |
| 86803 |
|
2,045 |
1,984 |
$23K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,679 |
3,426 |
$22K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
1,137 |
1,086 |
$18K |
| 83550 |
|
2,515 |
2,416 |
$17K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
1,096 |
1,052 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
755 |
734 |
$16K |
| 83540 |
|
2,648 |
2,549 |
$13K |
| 87536 |
|
189 |
183 |
$12K |
| 82746 |
|
1,043 |
1,009 |
$12K |
| 86780 |
|
1,110 |
1,056 |
$11K |
| 83880 |
|
382 |
357 |
$10K |
| 86235 |
|
149 |
130 |
$10K |
| 87081 |
|
1,768 |
1,677 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
15,569 |
13,801 |
$10K |
| 87077 |
|
1,455 |
1,380 |
$9K |
| 82043 |
|
2,615 |
2,529 |
$8K |
| 87186 |
|
1,211 |
1,146 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
156 |
147 |
$7K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
374 |
352 |
$7K |
| 83735 |
|
1,735 |
1,413 |
$7K |
| 86140 |
|
1,809 |
1,616 |
$7K |
| 83970 |
|
263 |
257 |
$7K |
| 80076 |
|
984 |
934 |
$6K |
| 84403 |
|
371 |
350 |
$6K |
| 82784 |
|
506 |
490 |
$6K |
| 82785 |
|
453 |
397 |
$6K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
13 |
13 |
$6K |
| 87340 |
|
632 |
611 |
$5K |
| 81001 |
|
1,918 |
1,828 |
$4K |
| 86038 |
|
457 |
441 |
$4K |
| 87150 |
|
217 |
209 |
$4K |
| 85652 |
|
1,887 |
1,687 |
$4K |
| 86361 |
|
164 |
160 |
$4K |
| 86364 |
|
210 |
198 |
$4K |
| 85610 |
|
897 |
703 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
117 |
113 |
$3K |
| 84146 |
|
193 |
185 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
84 |
78 |
$3K |
| 87070 |
|
443 |
422 |
$3K |
| 86225 |
|
252 |
240 |
$3K |
| 80074 |
|
66 |
66 |
$3K |
| 84481 |
|
228 |
224 |
$2K |
| 83001 |
|
142 |
140 |
$2K |
| 86258 |
|
103 |
101 |
$2K |
| 83655 |
|
189 |
179 |
$2K |
| 86160 |
|
130 |
122 |
$2K |
| 82533 |
|
134 |
111 |
$2K |
| 84702 |
|
230 |
183 |
$2K |
| 83516 |
|
83 |
72 |
$2K |
| 86334 |
|
111 |
109 |
$2K |
| 87205 |
|
466 |
440 |
$2K |
| 84402 |
|
111 |
103 |
$2K |
| 83690 |
|
295 |
284 |
$2K |
| 82024 |
|
115 |
92 |
$2K |
| 86431 |
|
403 |
388 |
$2K |
| 83721 |
|
180 |
179 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
35 |
26 |
$1K |
| 82378 |
|
97 |
84 |
$1K |
| 82105 |
|
103 |
100 |
$1K |
| 86706 |
|
191 |
189 |
$1K |
| 83615 |
|
260 |
236 |
$1K |
| 84480 |
|
107 |
101 |
$1K |
| 80164 |
|
105 |
103 |
$1K |
| 84550 |
|
349 |
325 |
$1K |
| 84153 |
|
76 |
74 |
$1K |
| 80069 |
|
195 |
188 |
$1K |
| 82570 |
|
282 |
273 |
$1K |
| 85046 |
|
226 |
219 |
$983.83 |
| 86376 |
|
85 |
84 |
$977.70 |
| 84100 |
|
435 |
304 |
$898.56 |
| 84165 |
|
68 |
65 |
$833.06 |
| 82565 |
|
195 |
165 |
$773.12 |
| 80197 |
|
67 |
38 |
$755.15 |
| 84460 |
|
189 |
187 |
$743.06 |
| 86300 |
|
130 |
122 |
$720.00 |
| 86800 |
|
54 |
53 |
$692.03 |
| 83883 |
|
77 |
72 |
$671.50 |
| 82550 |
|
112 |
98 |
$588.53 |
| 86850 |
|
258 |
243 |
$563.25 |
| 86008 |
|
40 |
40 |
$559.44 |
| 86762 |
|
84 |
83 |
$548.32 |
| 86618 |
|
43 |
42 |
$523.93 |
| 83002 |
|
29 |
29 |
$518.56 |
| 84156 |
|
193 |
187 |
$500.40 |
| 83010 |
|
44 |
44 |
$478.04 |
| 83921 |
|
27 |
26 |
$475.50 |
| 84450 |
|
191 |
186 |
$456.82 |
| 84436 |
|
83 |
80 |
$453.42 |
| 86704 |
|
49 |
49 |
$433.44 |
| 80373 |
|
44 |
44 |
$430.43 |
| 86900 |
|
221 |
209 |
$367.61 |
| 86901 |
|
221 |
209 |
$367.61 |
| 80177 |
|
42 |
41 |
$365.67 |
| 83520 |
|
25 |
25 |
$347.10 |
| 86039 |
|
45 |
44 |
$345.96 |
| 85730 |
|
74 |
72 |
$336.56 |
| 81003 |
|
185 |
182 |
$318.60 |
| 82950 |
|
138 |
129 |
$298.54 |
| 86200 |
|
28 |
27 |
$297.85 |
| 87102 |
|
50 |
47 |
$296.12 |
| 83525 |
|
39 |
37 |
$287.94 |
| 82465 |
|
86 |
79 |
$278.40 |
| 83020 |
|
26 |
26 |
$253.00 |
| 86705 |
|
79 |
78 |
$235.40 |
| 84681 |
|
13 |
13 |
$231.40 |
| 82150 |
|
43 |
37 |
$213.84 |
| 86696 |
|
12 |
12 |
$212.85 |
| 84425 |
|
31 |
30 |
$188.40 |
| 82172 |
|
13 |
13 |
$181.85 |
| 82977 |
|
30 |
29 |
$172.80 |
| 86480 |
|
61 |
60 |
$159.14 |
| 86592 |
|
44 |
43 |
$143.68 |
| 84478 |
|
30 |
27 |
$143.47 |
| 86787 |
|
16 |
16 |
$138.00 |
| 87899 |
|
12 |
12 |
$121.99 |
| 82947 |
|
29 |
27 |
$106.11 |
| 87427 |
|
12 |
12 |
$105.38 |
| 83718 |
|
18 |
17 |
$98.28 |
| 83521 |
|
18 |
18 |
$85.80 |
| 85018 |
|
39 |
38 |
$74.94 |
| 85014 |
|
39 |
38 |
$70.20 |
| 85379 |
|
27 |
27 |
$70.20 |
| 82248 |
|
14 |
13 |
$65.26 |
| 84520 |
|
19 |
12 |
$51.35 |
| 86593 |
|
12 |
12 |
$48.40 |
| 86709 |
|
53 |
53 |
$33.78 |